• A case of acute hypercapnic respiratory failure secondary to late onset nemaline rod myopathy: A multi-disciplinary approach
• A Case of Anti-Synthetase Syndrome With Anti-Glycyl tRNA Synthetases Antibody Developed After COVID-19
• A Case of COVID-19-Triggered Polymyositis Leading to Rhabdomyolysis
• A Case of Overlapping Autoimmune Syndrome
• A Rare Case of Anti-TIF-1γ Antibody Positive Dermatomyositis in Adulthood
• A Review of Myositis-Associated Interstitial Lung Disease
• Activity Prediction Modeling Based on a Combination of Growth Differentiation Factor 15 and Serum Biomarker Levels in Dermatomyositis and Polymyositis
• Amyopathic Dermatomyositis Presenting with Digital Ulcerations: Case Report and Literature Review
• Anasarca and spontaneous intramuscular haemmorhage in a dermatomyositis patient: case report and review of the literature
• Anti-HMGCR (Hydroxy-3-Methylglutaryl-CoA Reductase) Myopathy: A Rare Cause of Proximal Muscle Weakness
• Anti-melanoma differentiation-associated gene 5 (anti-MDA5) positive dermatomyositis: early detection is crucial
• Anti-melanoma differentiation-associated protein 5 associated dermatomyositis with hemophagocytic lymphohistiocytosis
• Anti-TIF1-γ Antibody-Positive Dermatomyositis Leading to Identification of Diffuse Large B-Cell Lymphoma
• Anti-TIF1-γ-associated dermatomyositis associated with recurrent metastatic triple-negative breast cancer: Dramatic clinical response to sacituzumab govitecan
• Anti‐TIF1‐γ‐assoziierte Dermatomyositis bei rezidivierendem metastasierendem dreifach‐negativem Brustkrebs: Dramatisches klinisches Ansprechen auf Sacituzumab‐Govitecan
• ASM is a therapeutic target in dermatomyositis by regulating the differentiation of naive CD4 + T cells into Th17 and Treg subsets
• Association between periungual changes and myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies: A retrospective cohort study
• Association of education attainment and risk of connective tissue diseases
• Atherosclerotic cardiovascular disease following a diagnosis of idiopathic inflammatory myopathy: analysis from a retrospective cohort in the TriNetX registry
• Autoimmune Myocarditis, Old Dogs and New Tricks
• Belimumab ameliorates symptoms and disease activity in patients with dermatomyositis and juvenile dermatomyositis refractory to standard therapy: A retrospective observational study
• Cancer and pulmonary fibrosis risks in patients with dermatomyositis and polymyositis: A retrospective cohort study
• Case report: "Fur stole and turtleneck" and "halter-back" signs: an expanded wardrobe for dermatomyositis
• Case report: Pneumatosis coli in an anti-TIF1-ɣ-positive dermatomyositis patient
• Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry
• Clinical importance of anti-Ro52 antibody for polymyositis and dermatomyositis
• Clinical utility of anti-Ro52 antibody confirmation in anti-MDA5 antibody-positive dermatomyositis: A case report
• Coexistence of anti-KS and anti-TIF1-γ antibodies in clinically amyopathic dermatomyositis presenting with rapid progression of interstitial lung disease
• Combination of cytoplasmic and nuclear patterns on Hep-2 antinuclear antibody is useful as a screening test for anti-synthetase syndrome
• Coordinated immune dysregulation in juvenile dermatomyositis revealed by single-cell genomics
• Correction for Ichimura et al., Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice
• Decreased Peripheral Blood Natural Killer Cell Count in Untreated Juvenile Dermatomyositis Is Associated with Muscle Weakness
• Dermatomyositis
• Dermatomyositis Associated With High-Grade B-Lymphoproliferative Disorders: A Case Report and Literature Review
• Dermatomyositis: nailfold capillaroscopy patterns and a general survey
• Diagnosing and characterizing inflammatory myopathies at an Australian tertiary public hospital: Resource utilization and direct healthcare costs
• Diagnosis of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis led by sarcoplasmic myxovirus resistance protein A expression on muscle pathology
• Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies
• Drug-Induced dermatomyositis following COVID-19 vaccination
• Elevated type I IFN signalling directly affects CD8⁺ T-cell distribution and autoantigen recognition of the skeletal muscles in active JDM patients
• Evaluation of the frequency and risk factors of spontaneous intramuscular hemorrhage associated with dermatomyositis
• Explore the shared molecular mechanism between dermatomyositis and nasopharyngeal cancer by bioinformatic analysis
• Exploring the link between inflammatory myopathies and cancer: A comprehensive retrospective analysis in a Colombian cohort
• Extracorporeal Membrane Oxygenation for Acute Lung Injury in Idiopathic Inflammatory Myopathies-A Potential Lifesaving Intervention
• Factors Associated With Complete Clinical Response and Remission in a Cohort of Romanian Children With Juvenile Dermatomyositis
• Familial clustering of dysbiotic oral and fecal microbiomes in juvenile dermatomyositis
• Fatal pulmonary arterial hypertension (PAH): A rare association of anti-MDA-5 positive juvenile dermatomyositis
• From machine learning to clinical practice: phenotypic clusters of anti-MDA5 antibody-positive dermatomyositis
• Identification and management of interstitial lung disease associated with systemic sclerosis (SSc-ILD), rheumatoid arthritis (RA-ILD), and polymyositis/dermatomyositis (PM/DM-ILD): development of expert consensus-based clinical algorithms
• Identification of common mechanisms and biomarkers for dermatomyositis and atherosclerosis based on bioinformatics analysis
• Identification of shared immune infiltration characteristic molecules in dermatomyositis and nasopharyngeal carcinoma using bioinformatics: Traits in dermatomyositis and nasopharyngeal cancer
• Idiopathic inflammatory myopathies : An interdisciplinary challenge
• Images in dermatology: Dermatomyositis
• Imatinib-induced dermatomyositis <em>sine dermatitis</em> - a rare case report
• Immune-related adverse events associated with mogamulizumab: a comprehensive review of the literature
• Immunohistochemical expression in idiopathic inflammatory myopathies at a single center in Vietnam
• Increased vascular deposition of oxidized LDL in untreated juvenile dermatomyositis
• Investigating the disparities among drug categories in drug-induced dermatomyositis: A systematic review
• Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report
• Juvenile-onset anti-nuclear matrix protein 2 (NXP-2) antibody-positive dermatomyositis with joint contractures before manifestation of myositis: a case report
• MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)
• Methotrexate Use and Risk of Interstitial Lung Disease in Dermatomyositis
• Microarray analysis of microrna expression in peripheral blood mononuclear cells of patients with polymyositis and dermatomyositis
• Mixed Connective Tissue Disease (MCTD) in a Girl with Lower Extremities Edema: A Brief Report
• Multivariate logistic regression analysis of poor prognosis of dermatomyositis and clinical value of ferritin/Kl-6 in predicting prognosis
• Myositis as a prominent manifestation of primary skeletal muscle peripheral T-cell lymphoma: a case report and literature review
• Novel Mutation in the Moesin (MSN) Gene Leads to Immunodeficiency with Epstein-Barr Virus (EBV) Infection and Dermatomyositis-Like Symptoms
• NXP-2 positive dermatomyositis with marked dysphagia following an insect bite
• Optimization of the Diagnostic Capacity of Traditional Biomarkers in Muscle Damage and Its Use in the Diagnosis of Dermatomyositis and Polymyositis
• Palmar and digital tip involvement in anti-MDA5 dermatomyositis
• Pathological autoantibody internalisation in myositis
• Patient Perspectives of the Manifestations and Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis: An Observational Survey
• Perspectives in the treatment of interstitial lung disease accompanied with anti-melanoma differentiation-associated gene 5-positive dermatomyositis
• Peru: 47 year old woman with polymyositis becomes country's first person to die with medical assistance
• Potential Mechanism and Therapeutic Targets of Polymyositis
• Predictors of hypothyroidism amongst dermatomyositis in-patients and an evaluation of financial and demographic differences based on thyroid status
• Predictors of relapse of polymyositis/dermatomyositis associated interstitial lung disease
• Preoperative management and postoperative complications in 9 dogs undergoing surgical treatment of thymic-associated myasthenia gravis
• Pretreatment mortality risk prediction model in patients with polymyositis/dermatomyositis-associated interstitial lung disease
• Prevalence of cutaneous manifestations and myositis-specific antibodies in COVID-19 patients and Anti-PL7 antibodies association with pulmonary radiological severity: A retrospective study
• Prognostic analysis of MDA5-associated clinically amyopathic dermatomyositis with interstitial lung disease
• Radiomics based on HRCT can predict RP-ILD and mortality in anti-MDA5 + dermatomyositis patients: a multi-center retrospective study
• Review of Pulmonary Manifestations in Antisynthetase Syndrome
• Scleroderma-Polymyositis Overlap Syndrome as a Potential Bulbar Amyotrophic Lateral Sclerosis Mimic
• Serum 25-hydroxyvitamin D levels and dermatomyositis: A 2-sample mendelian randomization study
• Sex-based differences in dermatomyositis: a retrospective study
• Soluble CXCL16 is a prognostic biomarker associated with rapidly progressive interstitial lung disease complicated with dermatomyositis
• Subcutaneous immunoglobulin for the treatment of calcinosis associated with juvenile dermatomyositis
• Successful Treatment of Ultrasound-confirmed Synovitis in Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Corticosteroid Therapy
• The Clinical Value of the Neutrophil-to-Lymphocyte Ratio, the C-Reactive Protein-to-Albumin Ratio, the Systemic Inflammatory Index, and the Systemic Inflammatory Response Index in Patients with the Anti-Synthetase Syndrome
• The Enemy within-Multifocal Tuberculous Abscesses Complicating Dermatomyositis
• The muscle tissue transcriptome of idiopathic inflammatory myopathy reflects the muscle damage process by monocytes and presence of skin lesions
• The prevalence, epidemiological characteristics and mortality trends of inflammatory myopathies patients in Oman: the Prevision study
• The relationship between infectious agents and juvenile dermatomyositis: a narrative update from the pediatric perspective
• The usefulness of nailfold capillaroscopy in scleroderma-spectrum disorders: a single-centre observational study
• Three cases of Anti-MDA5 positive dermatomyositis with interstitial lung disease and pneumomediastium
• Under the Surface: Malignancy Unveiled in a Young Woman with Dermatomyositis
• Upper Gastrointestinal (GI) Manifestations of Inflammatory Myositis: A Tale of Two Patients
• Use of tocilizumab to treat arthritis associated with mixed connective tissue disease complicated by ovarian teratoma: a case report
• Whole-body muscle magnetic resonance imaging in inflammatory myopathy with mitochondrial pathology